The National Cancer Institute, a part of the National Institutes of Health, announced release of the 2011 Phase II Bridge Award program. The grant will bridge the funding gap, or “valley of death”, between SBIR Phase II and Phase III projects and must be matched by third party investors.
As many as ten grants of up to $1 million per year for up to three years will awarded in 2011. Development efforts may include preclinical R&D or clinical trials in three project areas:
(1) cancer therapeutics
(2) cancer imaging technologies, interventional devices and in vivo diagnostics
(3) in vitro and ex vivo cancer diagnostics and prognostics
Complete information can be found on the National Cancer Institute’s SBIR announcements website.
To apply for the SBIR Phase II Bridge Award, a letter of intent must be submitted by March 7, 2011. Full applications are due by April 7.